insights_auto
Why is IKT down 4.35%?
Dive Deeperchevron_right
IKT:NASDAQ
Inhibikase Therapeutics Inc
$2.20
arrow_downward
-4.35%(-0.100) 1D
$2.24
arrow_upward
+1.82% (+0.040)bedtimeAfter hours
Closed: Sep 21, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IKT...
Open
$2.31
High
$2.32
Low
$2.20
Mkt. cap
306.98M
Avg. vol.
497.90K
Volume
366.10K
52-wk high
$2.61
52-wk low
$1.33
EPS
-$0.44
Beta
0.95
Shares outstanding
139.54M
No. of employees
35
Open
$2.31
High
$2.32
Low
$2.20
Mkt. cap
306.98M
Avg. vol.
497.90K
Volume
366.10K
52-wk high
$2.61
52-wk low
$1.33
EPS
-$0.44
Beta
0.95
Shares outstanding
139.54M
No. of employees
35
News stories
From web sources and news partners
careplusvn.com
·
3 weeks ago
IKT Q2 2026 Earnings: Slight EPS Miss Highlights Continued Clinical-Stage Investment - Analyst Drop Coverage
https://www.dars.gov.et/
·
1 month ago
IKT Q1 2026 Earnings: Narrower Loss of $0.10 Per Share Beats Estimates as Pre-Revenue Biotech Holds Steady
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteinhibikase.com